The coronavirus crisis has highlighted the EU's dependency on countries outside its borders for the production of many active pharmaceutical ingredients and medicines. It is not a new problem… but it has become painfully exposed in the past weeks. So, why is that? And what can the EU do about it? Never a debate has been timelier!
https://www.europarl.europa.eu/thinktank/en/document.html?reference=EPRS_BRI(2020)649402
Source: © European Union - EP